Celldex Price Target Lifted By: MarketMinute » Stock News September 23, 2013 at 10:27 AM EDT Leerink Swann lifted its price target on Celldex Therapeutics Inc. (Nasdaq: CLDX) from $28 to $45 per share sending the stock price soaring $3.72 to close at $32.68. Related Stocks: Celldex Therapeutics